» Articles » PMID: 25254220

Characteristics and Determinants of Partial Remission in Children with Type 1 Diabetes Using the Insulin-dose-adjusted A1C Definition

Overview
Journal J Diabetes Res
Publisher Wiley
Specialty Endocrinology
Date 2014 Sep 26
PMID 25254220
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

To evaluate the characteristics and determinants of partial remission (PR) in Belgian children with type 1 diabetes (T1D), we analyzed records of 242 children from our center. Clinical and biological features were collected at diagnosis and during follow-up. PR was defined using the insulin-dose-adjusted A1C definition. PR occurred in 56.2% of patients and lasted 9.2 months (0.5 to 56.6). 25.6% of patients entered T1D with DKA, which correlated with lower PR incidence (17.6% versus 82.3% when no DKA). In our population, lower A1C levels at diagnosis were associated with higher PR incidence and in young children (0-4 years) initial A1C levels negatively correlated with longer PR. Early A1C levels were predictive of PR duration since 34% of patients had long PRs (>1 year) when A1C levels were ≤ 6% after 3 months whereas incidence of long PR decreased with higher A1Cs. C-peptide levels were higher in patients entering PR and remained higher until 3 years after diagnosis. Initial antibody titers did not influence PR except for anti-IA2 titers that correlated with A1C levels after 2 years. Presence of 2 versus 1 anti-islet antibodies correlated with shorter PR. PR duration did not influence occurrence of severe hypoglycemia or diabetes-related complications but was associated with lower A1C levels after 18 months. We show that, at diagnosis of T1D, parameters associated with β-cell mass reserve (A1C, C-peptide, and DKA) correlate with the occurrence of PR, which affects post-PR A1C levels. Further research is needed to determine the long-term significance of PR.

Citing Articles

Pubertal stage significantly and independently impacts C-peptide levels at type 1 diabetes diagnosis along with body mass index and age.

Cimbek E, Beyhun N, Karaguzel G Eur J Pediatr. 2025; 184(3):219.

PMID: 40025382 PMC: 11872750. DOI: 10.1007/s00431-025-06046-3.


Better Cardiorespiratory Fitness Defined as VOmax Increases the Chance of Partial Clinical Remission and Prolongs Remission Duration in People with Newly Diagnosed Type 1 Diabetes.

Flotynska J, Naskret D, Niedzwiecki P, Grzelka-Wozniak A, Pypec A, Kaczmarek A Clin Med Insights Endocrinol Diabetes. 2024; 17:11795514241244872.

PMID: 38628617 PMC: 11020723. DOI: 10.1177/11795514241244872.


Islet autoantibodies as precision diagnostic tools to characterize heterogeneity in type 1 diabetes: a systematic review.

Felton J, Redondo M, Oram R, Speake C, Long S, Onengut-Gumuscu S Commun Med (Lond). 2024; 4(1):66.

PMID: 38582818 PMC: 10998887. DOI: 10.1038/s43856-024-00478-y.


Approaches to Measuring Beta Cell Reserve and Defining Partial Clinical Remission in Paediatric Type 1 Diabetes.

Kennedy E, Hawkes C Children (Basel). 2024; 11(2).

PMID: 38397298 PMC: 10887271. DOI: 10.3390/children11020186.


Honeymoon phase in type 1 diabetes mellitus: A window of opportunity for diabetes reversal?.

Mittal M, Porchezhian P, Kapoor N World J Clin Cases. 2024; 12(1):9-14.

PMID: 38292619 PMC: 10824181. DOI: 10.12998/wjcc.v12.i1.9.


References
1.
Martin S, Pawlowski B, Greulich B, Ziegler A, Mandrup-Poulsen T, Mahon J . Natural course of remission in IDDM during 1st yr after diagnosis. Diabetes Care. 1992; 15(1):66-74. DOI: 10.2337/diacare.15.1.66. View

2.
Akirav E, Kushner J, Herold K . Beta-cell mass and type 1 diabetes: going, going, gone?. Diabetes. 2008; 57(11):2883-8. PMC: 2570380. DOI: 10.2337/db07-1817. View

3.
Atkinson M, Bluestone J, Eisenbarth G, Hebrok M, Herold K, Accili D . How does type 1 diabetes develop?: the notion of homicide or β-cell suicide revisited. Diabetes. 2011; 60(5):1370-9. PMC: 3292309. DOI: 10.2337/db10-1797. View

4.
VanBuecken D, Greenbaum C . Residual C-peptide in type 1 diabetes: what do we really know?. Pediatr Diabetes. 2014; 15(2):84-90. DOI: 10.1111/pedi.12135. View

5.
Dost A, Herbst A, Kintzel K, Haberland H, Roth C, Gortner L . Shorter remission period in young versus older children with diabetes mellitus type 1. Exp Clin Endocrinol Diabetes. 2007; 115(1):33-7. DOI: 10.1055/s-2007-948214. View